The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Enhanced episodic‐like memory and kindling epilepsy in a rat model of tuberous sclerosis
Abstract
Tuberous sclerosis complex (TSC) is a common neurological autosomal‐dominant syndrome caused by mutations in the TSC1 or TSC2 genes. TSC starts in early childhood and is characterized by cerebral hamartomas (benign tumours), severe epilepsy and cognitive deficits such as mental retardation and autism. The hamartomas are characterized by loss of the remaining wild‐type TSC allele, and clinical data implicate cerebral hamartomas in the generation of epileptic seizures, which may play a significant role in the development of mental retardation. The TSC2 mutation predicts alterations in mitogen‐associated protein kinase (MAPK) and, together with the TSC1 mutation, in mammalian target of rapamycin (mTOR) signalling pathways. Both pathways are involved in neuronal plasticity. We therefore hypothesized that the heterozygous mutation itself, besides cerebral hamartomas, contributes to the pathogenesis of cognitive deficits and possibly also epilepsy. Here, we show that young adult TSC2+/– rats, which are virtually free of cerebral hamartomas, exhibit enhanced episodic‐like memory and enhanced responses to chemically‐induced kindling. The activation of cyclic adenosine monophosphate (cAMP) in the hippocampus results in stronger induction of phospho‐p42‐MAPK in TSC2+/– rats than in wild‐type animals. Thus, the cognitive phenotype and, possibly, epilepsy in TSC patients may result not only from the focal hamartomatous lesions but also, from altered neuronal plasticity in the heterozygous tissue.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“demonstrating that other disease mechanisms are involved[5](#R5),[9](#R9)–[11](#R11).”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [9]
In the citing paper
“our data show that tuberous sclerosis–related cognitive deficits are not necessarily the consequence of neuroanatomical abnormalities (that is, tubers) or seizures.”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [9]
In the citing paper
“Instead, behavioral analysis reveals enhancements in episodic-like memory[9](#R9)”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [9]
In the citing paper
“Of note, these rats show many features associated with tuberous sclerosis, but no behavioral deficits[9](#R9).”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [9]
Citations
Cites
Episodic memory: from mind to brain
Tulving, E. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135114 · Cited by 4,950
Episodic-like memory during cache recovery by scrub jays
Clayton, N. S., & Dickinson, A. (1998) · Nature · doi:10.1038/26216 · Cited by 1,464
Can animals recall the past and plan for the future?
Clayton, N. S., Bussey, T. J., & Dickinson, A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1180 · Cited by 658
Martin, K. C., Michael, D., Rose, J. C., Barad, M., Casadio, A., Zhu, H., & Kandel, E. R. (1997) · Neuron · doi:10.1016/s0896-6273(00)80330-x · Cited by 545
Research works printed but not linked: 38
- 10.1016/0166-2236(90)90135-W · DOI
- 10.1016/S0092-8674(00)81653-0 · DOI · Paper page
- 10.1016/S0166-4328(96)00160-X · DOI
- Davis S., 1992, The NMDA receptor antagonist D‐2‐amino‐5‐phosphonopentanoate (D‐AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro, J. Neurosci., 12, 21, 10.1523/JNEUROSCI.12-01-00021.1992 · DOI
- 10.1016/S0959-4388(03)00076-X · DOI
- 10.1038/189858b0 · DOI
- Gomez M. R., 1999, The Tuberous Sclerosis Complex
- 10.1038/ng0294-193 · DOI
- 10.1158/0008-5472.CAN-03-3277 · DOI
- 10.1016/j.neurobiolaging.2003.11.007 · DOI · Paper page
- 10.1017/S0033291702007092 · DOI · Paper page
- 10.1074/jbc.M402591200 · DOI
- 10.1016/S0092-8674(04)00115-1 · DOI · Paper page
- 10.1016/0166-4328(94)00156-A · DOI
- 10.1016/S0969-9961(03)00127-X · DOI
- 10.1016/j.tibs.2003.09.003 · DOI · Paper page
- 10.1016/S0896-6273(00)80987-3 · DOI
- 10.1093/jnen/59.3.188 · DOI
- 10.1016/S0896-6273(03)00404-5 · DOI
- 10.1046/j.1460-9568.2002.02100.x · DOI
- 10.1016/0013-4694(72)90177-0 · DOI
- 10.1073/pnas.95.26.15629 · DOI
- 10.1177/08830738040190091401 · DOI
- 10.1016/S0002-9440(10)63897-7 · DOI
- 10.1111/j.1471-4159.1990.tb04595.x · DOI
- 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8 · DOI
- 10.1016/j.eplepsyres.2004.07.001 · DOI
- 10.1016/j.conb.2004.04.001 · DOI
- 10.1073/pnas.012605299 · DOI · Paper page
- 10.1177/08830738040190090801 · DOI
- 10.1016/S0092-8674(00)80184-1 · DOI
- 10.1385/MN:27:1:99 · DOI
- 10.1523/JNEUROSCI.21-15-05484.2001 · DOI
- 10.1007/s00401-004-0865-8 · DOI
- 10.1074/jbc.270.27.16409 · DOI
- 10.2174/1566524043359791 · DOI
- 10.1073/pnas.91.24.11413 · DOI
- 10.1152/ajprenal.00234.2003 · DOI
Cited by
Sorted by citations
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Role of mTOR in physiology and pathology of the nervous system
Swiech, L., Perycz, M., Malik, A., & Jaworski, J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.015 · Cited by 338
Perl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
Krueger, D. A., Sadhwani, A., Byars, A. W., de Vries, P. J., Franz, D. N., Whittemore, V. H., Filip‐Dhima, R., Murray, D., Kapur, K., & Sahin, M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.494 · Cited by 133
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120
Metadata
- Authors
- Waltereit, R., Welzl, H., Dichgans, J., Lipp, H., Schmidt, W. J., & Weller, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2005-11-21
- Volume
- 96
- Issue
- 2
- Pages
- 407-413
- ISSN
- 0022-3042
- 1471-4159
- Cited by
- 72
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review